Minocycline, an antibiotic of the tetracycline family, has attracted considerable interest for its theoretical therapeutic applications in neurodegenerative diseases. However, the mechanism of action underlying its effect remains elusive. Here we have studied the effect of minocycline under excitotoxic conditions. Fluorescence and bioluminescence imaging studies in rat cerebellar granular neuron cultures using fura-2/AM and mitochondria-targeted aequorin revealed that minocycline, at concentrations higher than those shown to block inflammation and inflammation-induced neuronal death, inhibited NMDA-induced cytosolic and mitochondrial rises in Ca 2+ concentrations in a reversible manner. Moreover, minocycline added in the course of NMDA stimulation decreased Ca 2+ intracellular levels, but not when induced by depolarization with a high K + medium. We also found that minocycline, at the same concentrations, partially depolarized mitochondria by about 5-30 mV, prevented mitochondrial Ca 2+ uptake under conditions of environmental stress, and abrogated NMDAinduced reactive oxygen species (ROS) formation. Consistently, minocycline also abrogates the rise in ROS induced by 75 M Ca 2+ in isolated brain mitochondria. In search for the mechanism of mitochondrial depolarization, we found that minocycline markedly inhibited state 3 respiration of rat brain mitochondria, although distinctly increased oxygen uptake in state 4. Minocycline inhibited NADH-cytochrome c reductase and cytochrome c oxidase activities, whereas the activity of succinate-cytochrome c reductase was not modified, suggesting selective inhibition of complex I and IV. Finally, minocycline affected activity of voltage-dependent anion channel (VDAC) as determined in the reconstituted system. Taken together, our results indicate that mitochondria are a critical factor in minocycline-mediated neuroprotection.
Introduction
Minocycline, a semi-synthetic derivate of tetracycline, is under scientific debate as a potential therapeutic agent in neurological disease processes (for review see [1, 2] . Support for this new application of a time-tested antibiotic comes from observations that minocycline readily crosses the blood-brain barrier to the greatest extent of all of the tetracyclines and is well tolerated. It affords neuroprotection in experimental models of Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), and acute inflammation after brain trauma or cerebral ischemia [1, 3] . Although there are inconsistent reports that show detrimental effects in different models of neurodegeneration [4, 5] , numerous studies have focused on the mechanisms underlying minocycline-mediated cell protection. However, the possible mechanisms described so far are poorly understood and need to be clarified.
We and others have postulated that mitochondria could be the pharmacological target affected by minocycline to afford cytoprotection. Proton-translocation by components of the respiratory chain generates the mitochondrial inner membrane potential ( m). This transmembrane potential can be used to phosphorylate ADP to ATP or for Ca 2+ uptake into mitochondria [6] . When added to isolated mitochondria, minocycline is able to decrease the m, possibly preventing mitochondrial permeability transition pore (MPTP) opening and the subsequent release of cytochrome c. Furthermore, m is considered an important factor in the maintenance of mitochondrial homeostasis: both Ca 2+ uptake [7] and production of reactive oxygen species (ROS) are attenuated due to a decrease in m [8] . Thus, small changes in m may contribute to the cytoprotection mechanisms. Mitochondrial depolarization, caused by low concentrations of mitochondrial uncouplers, has been shown to be protective against NMDA-induced neuronal death [9] .
Garcia-Martinez EM et al., 6 We also studied different parameters describing mitochondrial functions. Our results suggest that minocycline, although at concentrations higher than those shown to block inflammation and inflammation-induced neuronal death [21] , prevents NMDA-induced excitotoxicity by diminishing NMDA-induced Ca 2+ entry and altering the m via mitochondrial Ca 2+ uptake.
The latter may be caused by activity changes in VDAC as well as the respiratory chain.
Materials and Methods

Chemicals.
Fura-2, hydroethidine, CM-H 2 DCFDA, TMRM and celenterazin were obtained from Invitrogen (Barcelona, Spain). Mitochondrial AEQ construct was a gift from Prof. Brulet (Paris, France). Culture media, sera and antibiotics are from Lonza. If not indicated otherwise, all other chemicals were purchased from Sigma or Merck.
Animals
For cerebellar granule cell cultures, 5-7-day-old Wistar rats were used. Brain mitochondria were isolated from 3-month-old male Wistar rats. All animals were housed at 22 ± 2°C with 12 h/12 h light/dark cycles and with full access to water and food. Animal experiments were carried out in accordance with the Guiding Principles for Research Involving Animals and Human Beings of the American Physiological Society, the Guidelines of the European Union Council (86/609/CEE), and the Spanish regulations (BOE 67/8509 -12, 1988 ) for the use of laboratory animals. Approval was obtained from the Scientific Committee of the Universities of Cádiz, Castilla-La Mancha, and Valladolid.
Cell Cultures
M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al., 7 Cerebellar granule cells were obtained as reported previously [22] , plated on poly-Llysine coated, 12 mm diameter glass coverslips. They were cultured in high-glucose, low K + , Dulbecco's modified Eagle's medium (DMEM, Gibco, Spain) plus 10% fetal bovine serum, 5% horse serum, 100 g/ml penicillin, and 100 g/ml streptomycin for 2 days. Then the culture medium was replaced by Sato's medium plus 5% horse serum (to avoid excessive proliferation of glia) and cultured for 2-4 days before experiments.
Cell viability studies
To study NMDA-induced toxicity, neuronal cultures maintained 7 days in vitro were incubated for 30 min with 100 M NMDA, 2 M Ca 2+ /Na + and 10 M glycine in saline solution. Treatments were terminated by washing cells three times with Krebs solution before incubating with regular medium. Minocycline was added 10 min before NMDA at different concentrations and maintained during the whole experiment. Cell viability was analyzed 24 h later using the fluorescein diacetate/ propidium iodide double-staining procedure. Living and dead cells were counted in 3-4 coverslips per condition (a total of 300-450 cells per coverslip) and normalized to corresponding controls. At least three independent experiments were used for quantification
Fluorescence imaging of cytosolic [Ca 2+ ]
Coverslips containing cerebellar granule cells were incubated in standard medium containing (in mM) NaCl 145, KCl 5, CaCl 2 1, MgCl 2 1, glucose 10, Hepes 10 (pH 7.42), and loaded with 4 M fura2/AM for 60 min at room temperature. Coverslips were then placed on the heated stage of an inverted Zeiss microscope (Axiovert S100 TV), and while continuously perfused with the same pre-warmed standard medium, epi-illuminated alternately at 340 and M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al.,
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(Hamamtsu Photonics, Hamamatsu, Japan). Pixel-by-pixel ratios of consecutive frames were captured, and [Ca 2+ ] cyt was estimated from these ratios as previously reported [23] .
Bioluminescence imaging of mitochondrial [Ca 2+ ]
Cerebellar granule cells were transfected with plasmids containing GFP-aequorin targeted to mitochondria [24] using a Nucleofector II ® device and the VPG-1003 transfection kit (Amaxa Biosystems, Cologne, Germany). After 24 h, cells were incubated for 1 h with 1 M coelenterazine, washed, and placed into a perfusion chamber set at 37 º C under a Zeiss Axiovert S100 TV microscope. They were then perfused at 5-10 ml/min with test solutions based on the standard perfusion solution pre-warmed to 37ºC as described above. At the end of each experiment, cells were permeabilized with 0.1 mM digitonin in 10 mM CaCl 2 in order to release all the residual aequorin counts. Bioluminescence images were taken with a Hamamatsu VIM photon counting camera handled with an Argus-20 image processor. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65 , with or without minocycline. Finally, perfusion was switched to "intracellular" medium containing 5 M Ca 2+ , with or without minocycline.
Mitochondrial potential
The effects of treatment on Δ in intact cerebellar granule cells were estimated by fluorescence imaging of cells loaded with the Δ sensitive probe tetramethylrhodamine methyl ester (TMRM), one the most sensitive probes available [25] . Briefly, cerebellar granule cells were loaded with 10 nM TMRM for 10 min, washed with a standard, external medium, and placed on the perfusion chamber of a Zeiss Axiovert S100 TV inverted microscope. Cells were then continuously perfused with pre-warmed (37ºC) external medium, with and without treatments. Fluorescence images were taken at 10 s intervals with a
Hamamatsu VIM photon counting camera handled with an Argus-20 image processor. Traces from individual cells were normalized relative to the value before the addition of either vehicle or treatment and averaged. Background fluorescence after collapse of the mitochondrial potential induced by 10 M FCCP was subtracted. Further details have been reported previously [26] .
M a n u s c r i p t 
Superoxide intracellular production
Superoxide production was monitored using hydroethidine (HEt, Molecular Probes) as described previously [27] . Coverslips containing cerebellar granule cells were incubated in standard medium containing (in mM): NaCl 145, KCl 5, CaCl 2 1, MgCl 2 1, glucose 10, and ) production.
Isolation of mitochondria and preparation of mitochondrial membranes
Brain mitochondria were isolated from the whole rat brain in a small Potter homogenizer with a Teflon pestle. Homogenization was carried out in a medium of 230 mM mannitol, 70 mM sucrose, 1.0 mM EDTA, and 10 mM Tris-HCl, pH 7.40, at a ratio of 9 ml of homogenization medium/g of tissue. The homogenate was centrifuged at 700 g for 10 min and the supernatant at 8,000 g for 10 min to precipitate mitochondria that were washed in the same conditions [28] . The obtained mitochondrial suspensions of about 20 mg protein/ml were used immediately after isolation for the determination of respiration or frozen in liquid N 2 and kept at -80°C. Sub-mitochondrial membranes (disrupted mitochondria) were obtained from brain mitochondria that were twice frozen-and-thawed and homogenized each time by passage through a tuberculin needle. The procedure yielded a preparation of disrupted mitochondria with 0.20-0.24 nmol cytochrome aa 3 /mg protein, subsequently used for the determination of enzymatic activity of the respiratory complexes and the presence of markers 
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of oxidative damage. The protein content of the samples was determined using Folin reagent and bovine serum albumin as the standard. To study the effects of minocycline, the braincoupled mitochondria or sub-mitochondrial membranes were added or incubated for 5 min at 4ºC, respectively, with 0, 75, 100, 125, or 150 M minocycline.
Mitochondrial oxygen uptake
The oxygen uptake of rat brain mitochondria (0.7-0.8 mg/ml) was determined with a 
Measurement of ROS levels in mitochondrial suspension
Mitochondrial ROS production was evaluated with the fluorescent probe 5-(and 6-)- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al.,
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each experimental point. The average of relative DFCA fluorescence from at least three separate mitochondrial preparations was determined. Results are expressed as mean ± SEM values.
Mitochondrial electron transfer activity
The enzymatic activity of Complexes I-III, II-III, and IV were determined determines the electron transfer rates of physiological respiration [29] . Three determinations for each value.
DPPH radical-scavenging activity
The scavenging activity of minocycline was measured according to the method described by Brand-Williams et al. [30] with some modifications. Briefly, 500 l of minocycline methanolic solutions (100 M) at different concentrations (12.5 to 150 l/ml) were added to 1 mL of 2,2-diphenyl-1-picrylhydrazyl (DPPH•) methanolic solution (0.1 mM).
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Estimated time of reaction (20 min) was determined considering the reduction of absorbance at 517 nm (monitored every 5 minutes) until the reaction curve reached a plateau. The absorbance was measured at room temperature, in darkness, with a blank (500 l of sample plus 1 ml of methanol). The absorbance of the control (500 l of methanol in 1 ml of DPPH• solution) was measured daily. All of the assays were conducted in triplicate. The percentage activity for the DPPH• technique was calculated according to % discoloration = [1 -(Abs sample/Abs control)] x 100.
Ferric reducing ability assay
The ferric reducing ability of minocycline was measured according to the method developed by Benzie and Strain (1996) [31] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al.,
Isolation of VDAC from Saccharomyces cerevisiae mitochondria
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The yeast Saccharomyces cerevisiae M3 cells (MAT , lys2, his4, trp1, ade2, leu2, ura3) [32] were grown at 28ºC in YPG medium (1% yeast extract, 2% peptone, 3% glycerol) at pH 5.5 to OD 546 of 2.2. Mitochondria and the mitochondrial outer membrane were isolated according to the published procedure [33] . The obtained outer membrane pellet was suspended in the solubilization buffer containing 3% Triton X-100, 10 mM Tris-HCl (pH 7.0), and 1 mM EGTA, incubated for 30 min at 0ºC. The suspension was then loaded onto a dry hydroxyapatite/celite column [34] and the first two fractions were collected. Before reconstitution, the preparations of VDAC were checked by Western blotting with anti-yeast anti-serum for the presence of marker proteins of mitochondrial compartments as well as for VDAC (not shown). Instruments) and computer software was used for data collection. The average amount of analyzed insertion events for a given set of conditions was 70.
Conductance measurements in planar phospholipid membranes
Statistics
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When only two means were compared, Student's t test was used. For more than two groups, statistical significance of the data was assessed by analysis of the variance (ANOVA) and compared using Turkey's test. Differences were considered significant at p<0.05. For the conductance measurements in planar phospholipid membranes, the differences between calculated values of average conductance were tested by t-test (at = 0.01) for statistical significance.
Results
Minocycline and cell viability
Consistent with previous data from our laboratory and elsewhere, minocycline afforded cytoprotection to neuronal cultures when exposed to excitotoxic conditions. Cerebellar granular cells were treated with minocycline at different concentrations (1-150 M) and challenged with NMDA (100 M) during 30 min. Twenty four hours later, neuronal viability was evaluated by using fluorescein diacetate and the propidium iodide staining method. As shown in Fig. 1 , NMDA treatment decreased cell viability by about 35% (p<0.05). Pre-treatment with minocycline, which did not affect cell viability (Figure 1 , black bars), afforded neuroprotection in a concentration-dependent manner. Concentrations lower than 50 M did not significantly modify NMDA-induced cell death ( Fig. 1 ).
Minocycline and calcium signals
It has been clearly established that NMDA-induced cell death depends on Ca 2+ entry through the plasma membrane and mitochondrial Ca 2+ uptake [12] . We therefore studied the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65 Fig. 2A) . This result is consistent with our previous findings that minocycline decreases the amplitude and the number of excitatory postsynaptic currents with EC 50 between 42 and 64 M, indicating that glutamatergic synaptic transmission is drastically affected by neuroprotective concentrations of minocycline (30 M or higher [35] ).
To study the effects of minocycline on [Ca 2+ ] mit cerebellar granule cells were transfected with mitochondria-targeted aequorin, a bioluminescent probe widely used for subcellular Ca 2+ measurements [22, 23] . This probe also contains GFP to help selecting transfected cells for bioluminescence imaging. Cerebellar granule cells were transfected with the GA plasmid and incubated for 24 h to allow for the expression of the Ca 2+ probe. Fig. 2B shows the bioluminescence (AEQ) and fluorescence (GFP) images of transfected cerebellar granule cells. We found that NMDA, in the presence of 100 M minocycline, failed to induce any rise in [Ca 2+ ] mit . However, after removal of minocycline, NMDA promoted the increase in [Ca 2+ ] mit (n=2). Thus, these results indicate that minocycline inhibits both the cytosolic and the mitochondrial rises in Ca 2+ concentrations induced by NMDA in a reversible manner.
To address whether minocycline inhibits the increase in [Ca 2+ ] cyt in a specific manner, we studied the effects of minocycline on [Ca 2+ ] cyt induced by either NMDA or high K + medium, added here to promote opening of voltage-gated Ca 2+ channels. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al.,
representative experiments. These data indicate that minocycline does not inhibit voltagegated Ca 2+ channels that can be activated by NMDA-induced plasma membrane depolarization.
In the next set of experiments we studied whether minocycline may affect the mitochondrial inner membrane potential and mitochondrial Ca 2+ uptake acting on intact cells.
Cerebellar granule cells were loaded with the mitochondrial inner membrane potential probe TMRM and subjected to fluorescence microscopy. We have shown previously that decreases in TMRM can be used to estimate mitochondrial potential decrements [12] . According to the algorithm proposed [12] , we estimate that minocycline, at 10-100 M, depolarizes mitochondria in intact cerebellar granule cells by 5-30 mV.
We have reported recently that a weak depolarization of mitochondria may largely influence mitochondrial Ca 2+ uptake [23] . Accordingly, we studied whether minocycline inhibited mitochondrial Ca 2+ uptake in permeabilized cells exposed to Ca 2+ concentrations similar to those achieved in Ca 2+ microdomains (10 μM). Cerebellar granule cells were transfected with the GA plasmid and incubated for 24 h. Then cells were incubated with 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al.,
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digitonin and subjected to bioluminescence imaging. Fig. 4B shows that addition of Ca 2+ to permeabilized cells in the presence of 100 M minocycline failed to rise [Ca 2+ ] mit. After removal of minocycline, addition of Ca 2+ induced release of photonic emissions corresponding to a increase in [Ca 2+ ] mit (n=36 cells, 6 independent experiments). Therefore, these results indicate that minocycline induces mitochondrial depolarization to such an extent that inhibits mitochondrial Ca 2+ uptake.
Minocycline and ROS production
Increasing amount of data indicates that ROS play a major role in the pathogenesis of neurodegenerative disorders [16] and also in excitotoxic cell death models [36] . As shown in In order to ascertain whether minocycline blocked ROS production at the mitochondrial level, we used CM-H 2 DCFDA to measure peroxide-like formation in brain isolated mitochondria challenged with high Ca 2+ . First, minocycline decreased basal mitochondrial ROS production (Fig. 5B ). The addition of 75 M Ca 2+ to the mitochondrial suspension resulted in a significant increase in the production of ROS (2.8 fold increase).
Minocycline inhibited this increase (Fig. 5B ). In addition, the mitochondrial uncoupler FCCP (10 μM) was also able to inhibit the increase in ROS production induced by the applied concentration of Ca 2+ (Fig. 5B ).
Taking into account these results, we went further to explore whether minocycline might function as a superoxide dismutase (SOD) or a catalase mimetic in a cell free system.
Our results revealed that minocycline does not show any of the above mentioned enzymatic activities (data not shown). Interestingly, and consistent with previous data, minocycline showed a diphenylpicrylhydrazyl (DPPH) radical scavenger activity [37] , an effect that reached statistical significance at a concentration of 25 μM and above (Fig. 5C ). Furthermore, our data also confirmed that minocycline mediated the reduction of Fe 3+ to Fe 2+ , at concentrations higher than 10 µM (Fig. 5D ).
Minocycline-induced effects on mitochondrial function
The O 2 uptake of isolated rat brain mitochondria was determined in resting state, in phosphorylating state and in uncoupled state triggered by FCCP. Malate-glutamate and succinate were used as respiratory substrates in the presence of minocycline in the range of 75-125 µM. Fig. 6 and 7 present typical recordings of the oxygen uptake obtained in the presence of 125 M minocycline for phosphorylating state (Fig. 6 ) and resting and uncoupled states ( Fig. 7) . 
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mitochondrial outer membrane as minocycline did not cause increase in cytochrome c release (not shown). Fig. 8 summarizes the effect of different concentrations of minocycline on the oxygen uptake during the studied respiratory states. Independently of the studied respiratory substrate we observed minocycline-concentration dependent inhibition of phosphorylating and uncoupled states and stimulation of resting state. However, the obtained calibration curves differed in shape between malate-glutamate and succinate that suggests differences of the applied mechanisms. Therefore we analyzed the influence of minocycline on enzymatic activities of the respiratory chain complexes I+III (NADH-cytochrome c reductase), II+III (succinate-cytochrome c reductase), and IV (cytochrome c oxidase). As shown in Fig. 9 , minocycline in the range of 75-150 µM inhibited markedly complexes I+III and IV. Thus minocycline appeared to affect the oxygen uptake supported by malate-glutamate at the level of complexes I and IV and the oxygen uptake supported by succinate only at the level of complex IV.
Minocycline affects VDAC conductance and voltage dependence
There is a growing amount of data showing that the voltage dependent anion channel (VDAC) is a dynamic regulator, or governor, of mitochondrial functions (for review see [17, 18] . Therefore we have studied the effects of minocycline on channel-forming activity of VDAC reconstituted into lipid bilayers. It was achieved by adding VDAC preparation to the aqueous phase of one side (so called cis side) of a black membrane bilayer made of asolectin.
It is well known that VDAC behavior in planar phospholipid membranes made of asolectin is voltage dependent and symmetrical [38] [39] [40] , meaning that the channel closes at about the same rate and to about the same extent depending on the applied potential value but regardless its sign. Thus, VDAC reconstituted into planar phospholipid membranes displays the ability to adopt a fully open state and multiple closed states of significantly smaller conductance that differ in permeability. The VDAC protein was isolated from mitochondria of the yeast Saccharomyces cerevisiae that contain only one channel-forming VDAC isoform [41] and are commonly used as a model to study mitochondrial biology. Since 100 M minocycline did not change formation and stability of the planar phospholipid membrane, we 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al.,
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probability of a channel occurrence in a given conductance state depending on the value of the applied potential [32, 42] . As shown in Fig. 10D , in the absence as well as in the presence of minocycline an increase in the value of the applied potential facilitated closure of the studied channels that resulted in a decrease of the value of an average conductance calculated for a given potential (G). This, in turn, caused a decrease in the value of the ratio G/G o , where G o denotes an average conductance at the lowest applied potential (10 mV). The sign of the applied potential did not influence these changes. However, in the presence of minocycline the VDAC voltage dependence was less pronounced and the weakening was concentrationdependent.
Discussion
The present data, built upon our group's previous work [22, 35, 43] , posits the intricate involvement of mitochondria in minocycline-mediated cytoprotection for neuronal cells.
Following excitotoxic NMDA receptor activation, the accumulation of Ca 2+ and the generation of ROS are modulated as minocycline targets mitochondria. Intervention with minocycline may prove useful as these are two events that occur early in neurodegenerative processes.
Consistent with previous observations [44, 45] , minocycline afforded cytoprotection to neuronal cultures under conditions of NMDA receptor-mediated excitotoxicity, although at a concentration range higher than that needed to block inflammation and inflammation-induced neuronal death [21] . In cultures pre-treated with minocycline, the NMDA-induced [Ca 2+ ] cyt rise was dramatically inhibited. We can exclude this effect as a consequence of the well established association between tetracyclines and Ca 2+ buffer capacity [43] . Minocycline failed to modify the intracellular levels of Ca 2+ in resting conditions, and did not attenuate a Ca 2+ increase following cellular depolarization with 50 mM KCl. Our data also revealed that 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65 induced by intrathecal NMDA [46] , or shed some light on the favourable effects of minocycline in a therapeutic window between 6 and 24 hours after a stroke [47] .
Minocycline does more than just preventing Ca 2+ fluxes at the plasma membrane. It also reduced [Ca 2+ ] mit overload, a pivotal role in excitotoxicity and other models of cell death [9, 12, 15] . By using bioluminescence imaging with mitochondria-targeted aequorin, we directly observed the effects of minocycline on NMDA-induced mitochondrial Ca 2+ overload.
This effect remained in permeabilized cells as minocycline abrogated mitochondrial Ca 2+ uptake induced by Ca 2+ concentrations that surpass the activation of the mitochondrial Ca 2+
uniporter. Supporting the hypothesis that small changes in mitochondrial potential may dramatically influence mitochondrial Ca 2+ uptake, minocycline, at 100 M, decreased by about 5-30 mV the m in cerebellar granular cells. Therefore, minocycline reduces the electrochemical driving force required for mitochondrial Ca 2+ uptake, resulting in the prevention of [Ca 2+ ] mit overload in excitotoxicity. Accordingly, prevention of mitochondrial Ca 2+ uptake by the mitochondrial Ca 2+ uncoupler FCCP largely abrogated NMDA-induced cell death [9] . Therefore, minocycline inhibit mitochondrial Ca 2+ overload induced by NMDA acting both at the plasma membrane level and at the mitochondrial level. These two actions seem independent as FCCP does not prevent NMDA-induced Ca 2+ influx (data not shown).
Minocycline also weakened ROS production, both in cultured neurons and in isolated mitochondria. Minocycline reduced the rate of increase of hydroethidine oxidation in neurons exposed to NMDA. Minocycline also reduced peroxide-like generation in isolated mitochondria suspensions when challenged with 75 M Ca 2+ . Similar to minocycline's effect M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al.,
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on m, this anti-oxidant action was mimicked by the mitochondrial uncoupler FCCP. We can not exclude a structure-dependent anti-oxidant effect of minocycline, since previous findings [48] have shown a direct DPPH radical scavenging property and the capacity to reduce Fe 3+ . However, such properties failed to afford SOD or catalase activity of minocycline. We have previously shown that minocycline does not prevent malonate-induced peroxide formation in cerebellar granular cell [22] , and is unable to prevent ROS-mediated MPTP opening that supporting the above statement [43] .
Consistent with a role of mitochondria as a target of minocycline-mediated neuroprotection, we found that minocycline affects distinctly activity of the respiratory chain although the observed effect is rather complicated.. First, minocycline inhibits complex I and complex IV of the respiratory chain. Interestingly, only these two complexes are true proton pumps within the respiratory chain able to physically move protons across a membrane [49] .
Nevertheless, the observed inhibition occurs in phosphorylating and uncoupled states supported by malate-glutamate or by succinate. On the other hand, the inhibition limits uncoupling capacity of uncoupler (FCCP) although minocycline added during resting state stimulate the oxygen uptake that might be caused by uncoupling as minocycline is able to decrease the inner membrane potential. However, the uncoupling effect is rather week when compared to that of FCCP. The apparent contradictory effects of minocycline on mitochondrial respiration (i.e., stimulation vs. inhibition) have been, in part, previously reported for others drugs such as local anaesthetics [50] . Since activation of NMDA receptors responsible for excitotoxicity imposes a high energetic demand on the in situ mitochondria [51] one could hypothesize that minocycline exerts its neuroprotective effect by affecting bioenergetic functions of mitochondria. Indeed, this effect could be responsible for the recent report showing that minocycline has a harmful effect on patients with ALS [52] . Accordingly, it was proposed by Kupsch et al. [53] that minocycline impairs mitochondria functions M a n u s c r i p t 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Garcia-Martinez EM et al., 25 causing dissipation. Subsequently, deenergized mitochondria lose the ability to undergo Ca 2+ -triggered MPTP resulting in cell death.
Minocycline might also act as a modulator of the voltage dependent anion channel (VDAC). Minocycline added to a reconstituted system caused VDAC transition into lowerconductance states and decreased the voltage dependence in a concentration-dependent way.
Thus, in the presence of minocycline the voltage dependence of reconstituted VDAC is weaker although simultaneously the channel is modified to assume lower conductance states that suggests an effect of minocycline on VDAC gating mechanism [39] . Furthermore flickering of VDAC conductance observed in the presence of minocycline might result from VDAC transient blockade/closure [54] . This, in turn, could have anti-apoptotic effects [19] .
Moreover, VDAC closing is accompanied by a change of its selectivity toward cations (e.g. [38, 40] ). However, it has been recently proven that VDAC also has a cation selective open state [55] . Therefore, it was proposed by Mannella and Kinnally [18] that VDAC modulators triggering a transition to lower conductance states might not be acting to close but to open.
Nevertheless in the presence of minocycline, the permeability of the mitochondrial outer membrane that is mediated by VDAC might be affected, thus contributing to neuroprotection.
In support of this view is the neuroprotective activity of rasagiline, a known anti-Parkinsonian drug, related to its ability to modulate VDAC [56] . Noteworthy, minocycline does not change formation or stability of the planar phospholipid membrane as measured by reconstitution experiments. This implies the absence of nonspecific perturbations of lipid membranes by minocycline. However, it can not be excluded that minocycline acts at the protein-lipid interface causing redistribution of membrane lateral pressure sensed by specific membrane proteins [57] .
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Figure legends
33
were averaged to calculate the slope. The mean slope values were used to generate a theoretical line using the following equation 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 The dependence of VDAC on the applied potential in the presence of minocycline increasing concentrations. G/G 0 is the ratio of the conductance (G) at a given voltage and the conductance (G 0 ) at the lowest applied potential (10 mV). The average amount of analysed insertion events for a given conditions used to calculate average conductance was 70. The obtained values of average conductance were statistically different.
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